autologous-autologous tandem hematopoietic stem cell transplantation

PROCEDURE7 trials

Sponsors

City of Hope Medical Center, SWOG Cancer Research Network, Case Comprehensive Cancer Center, Roswell Park Cancer Institute

Conditions

Adult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)Adult Acute Myeloid Leukemia in Remission

Phase 1

Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma

CompletedNCT00112827

City of Hope Medical CenterRefractory Multiple Myeloma, Smoldering Multiple Myeloma, Stage III Multiple Myeloma +2

Start: 2004-11-30End: 2019-02-15Updated: 2025-06-06

Phase 2

Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

CompletedNCT00182793

City of Hope Medical CenterBreast Cancer

Start: 2005-07-31End: 2014-10-31Updated: 2017-02-23

S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma

CompletedNCT00233987

SWOG Cancer Research NetworkLymphoma

Start: 2005-10-31End: 2017-12-31Updated: 2018-03-01

Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma

CompletedNCT00265889

Case Comprehensive Cancer CenterLymphoma

Start: 2002-02-28End: 2010-04-30Updated: 2013-11-20

S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia

WithdrawnNCT00723658

SWOG Cancer Research NetworkLymphoma

Start: 2008-09-30Updated: 2015-03-06

S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

WithdrawnNCT01055301

SWOG Cancer Research NetworkMultiple Myeloma, Plasma Cell Myeloma

Start: 2011-07-31End: 2011-07-31Updated: 2015-03-06

Unknown Phase

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

CompletedNCT00536601

Roswell Park Cancer InstituteAdult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities +56

Start: 2006-06-29End: 2018-07-09Updated: 2021-04-22

Related Papers

Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703).

2017-12-2811 citations

Total marrow irradiation (TMI) with helical tomotherapy and peripheral blood progenitor cell rescue (PBPC) following high-dose melphalan (Mel) and PBPC as part of tandem autologous transplant (TAT) for patients with multiple myeloma.

Journal of Clinical Oncology2015-05-203 citations